These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 23351020)

  • 41. Insulin-like growth factor (IGF) system components in human prostatic cancer cell-lines: LNCaP, DU145, and PC-3 cells.
    Kimura G; Kasuya J; Giannini S; Honda Y; Mohan S; Kawachi M; Akimoto M; Fujita-Yamaguchi Y
    Int J Urol; 1996 Jan; 3(1):39-46. PubMed ID: 8646598
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prolactin enhances insulin-like growth factor I receptor phosphorylation by decreasing its association with the tyrosine phosphatase SHP-2 in MCF-7 breast cancer cells.
    Carver KC; Piazza TM; Schuler LA
    J Biol Chem; 2010 Mar; 285(11):8003-12. PubMed ID: 20080972
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin receptor isoforms and insulin-like growth factor receptor in human follicular cell precursors from papillary thyroid cancer and normal thyroid.
    Malaguarnera R; Frasca F; Garozzo A; Gianì F; Pandini G; Vella V; Vigneri R; Belfiore A
    J Clin Endocrinol Metab; 2011 Mar; 96(3):766-74. PubMed ID: 21123448
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Decorin: a guardian from the matrix.
    Neill T; Schaefer L; Iozzo RV
    Am J Pathol; 2012 Aug; 181(2):380-7. PubMed ID: 22735579
    [TBL] [Abstract][Full Text] [Related]  

  • 45. RACK1, an insulin-like growth factor I (IGF-I) receptor-interacting protein, modulates IGF-I-dependent integrin signaling and promotes cell spreading and contact with extracellular matrix.
    Hermanto U; Zong CS; Li W; Wang LH
    Mol Cell Biol; 2002 Apr; 22(7):2345-65. PubMed ID: 11884618
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti-IGF-IR antibody.
    Wang Y; Hailey J; Williams D; Wang Y; Lipari P; Malkowski M; Wang X; Xie L; Li G; Saha D; Ling WL; Cannon-Carlson S; Greenberg R; Ramos RA; Shields R; Presta L; Brams P; Bishop WR; Pachter JA
    Mol Cancer Ther; 2005 Aug; 4(8):1214-21. PubMed ID: 16093437
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Novel role of cannabinoid receptor 2 in inhibiting EGF/EGFR and IGF-I/IGF-IR pathways in breast cancer.
    Elbaz M; Ahirwar D; Ravi J; Nasser MW; Ganju RK
    Oncotarget; 2017 May; 8(18):29668-29678. PubMed ID: 27213582
    [TBL] [Abstract][Full Text] [Related]  

  • 48. p66shc negatively regulates insulin-like growth factor I signal transduction via inhibition of p52shc binding to Src homology 2 domain-containing protein tyrosine phosphatase substrate-1 leading to impaired growth factor receptor-bound protein-2 membrane recruitment.
    Xi G; Shen X; Clemmons DR
    Mol Endocrinol; 2008 Sep; 22(9):2162-75. PubMed ID: 18606861
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Insulin-like growth factor receptor as a therapeutic target in head and neck cancer.
    Barnes CJ; Ohshiro K; Rayala SK; El-Naggar AK; Kumar R
    Clin Cancer Res; 2007 Jul; 13(14):4291-9. PubMed ID: 17634559
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The IGF system in thyroid cancer: new concepts.
    Vella V; Sciacca L; Pandini G; Mineo R; Squatrito S; Vigneri R; Belfiore A
    Mol Pathol; 2001 Jun; 54(3):121-4. PubMed ID: 11376121
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Insulin-like growth factor I receptor blockade enhances chemotherapy and radiation responses and inhibits tumour growth in human gastric cancer xenografts.
    Min Y; Adachi Y; Yamamoto H; Imsumran A; Arimura Y; Endo T; Hinoda Y; Lee CT; Nadaf S; Carbone DP; Imai K
    Gut; 2005 May; 54(5):591-600. PubMed ID: 15831900
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Decorin activates Akt downstream of IGF-IR and promotes myoblast differentiation.
    Suzuki K; Kishioka Y; Wakamatsu J; Nishimura T
    Anim Sci J; 2013 Sep; 84(9):669-74. PubMed ID: 23607268
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MicroRNA-145 directly targets the insulin-like growth factor receptor I in human bladder cancer cells.
    Zhu Z; Xu T; Wang L; Wang X; Zhong S; Xu C; Shen Z
    FEBS Lett; 2014 Aug; 588(17):3180-5. PubMed ID: 24999188
    [TBL] [Abstract][Full Text] [Related]  

  • 54. IGF-I receptor as an emerging potential molecular-targeted for hepatocellular carcinoma in vitro and in vivo.
    Yao M; Wang L; Yang J; Yan X; Cai Y; Yao D
    Tumour Biol; 2016 Nov; 37(11):14677-14686. PubMed ID: 27623941
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of insulin-like growth factor type I (IGF-I) receptor kinase activity by protein tyrosine phosphatase 1B (PTP-1B) and enhanced IGF-I-mediated suppression of apoptosis and motility in PTP-1B-deficient fibroblasts.
    Buckley DA; Cheng A; Kiely PA; Tremblay ML; O'Connor R
    Mol Cell Biol; 2002 Apr; 22(7):1998-2010. PubMed ID: 11884589
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regulation of decorin by ursolic acid protects against non-alcoholic steatohepatitis.
    Zheng Y; Huang C; Zhao L; Chen Y; Liu F
    Biomed Pharmacother; 2021 Nov; 143():112166. PubMed ID: 34560554
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Insulin-like growth factor receptor-1 as an anti-cancer target: blocking transformation and inducing apoptosis.
    Wang Y; Sun Y
    Curr Cancer Drug Targets; 2002 Sep; 2(3):191-207. PubMed ID: 12188907
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Insulin-like growth factor and insulin receptors in intestinal mucosa of neonatal calves.
    Georgiev IP; Georgieva TM; Pfaffl M; Hammon HM; Blum JW
    J Endocrinol; 2003 Jan; 176(1):121-32. PubMed ID: 12525256
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interactions between IGF-I, estrogen receptor-α (ERα), and ERβ in regulating growth/apoptosis of MCF-7 human breast cancer cells.
    Mendoza RA; Enriquez MI; Mejia SM; Moody EE; Thordarson G
    J Endocrinol; 2011 Jan; 208(1):1-9. PubMed ID: 20974640
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional evaluation of novel soluble insulin-like growth factor (IGF)-II-specific ligand traps based on modified domain 11 of the human IGF2 receptor.
    Prince SN; Foulstone EJ; Zaccheo OJ; Williams C; Hassan AB
    Mol Cancer Ther; 2007 Feb; 6(2):607-17. PubMed ID: 17308058
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.